Lungs News and Research

RSS

Women who initiate hormone therapy closer to menopause tend to have a reduced risk of coronary heart disease

Studies examining the effects of the use of postmenopausal hormone therapy on coronary heart disease (CHD) have yielded mixed results, depending on the type of study conducted. There may be a number of reasons for the differences, including the timing of initiation of hormone therapy, according to background information in the article.

4 Apr 2007

New way of making artificial lungs more efficient

Artificial lungs are cumbersome beasts, but they can be a lifesaver for people with serious respiratory diseases or lung damage. Sitting outside the body, they take over the task of soaking up excess carbon dioxide from the blood and infusing it with oxygen.

4 Apr 2007

Scientists identify new molecule that may help regulate the delivery of fats to cells

Published in the April issue of the journal Cell Metabolism, the finding could lead to a better understanding of how we utilize fats from the foods we eat.

4 Apr 2007

Harvard presents to Motion Picture Association of America on depiction of smoking in movies

Harvard School of Public Health (HSPH) is releasing materials presented to the Motion Picture Association of America (MPAA) in a scientific briefing requested by the MPAA last February 23, 2007 in Hollywood on the health impact of youth smoking and the behavioral influence of films that depict tobacco use.

3 Apr 2007

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause

Secondary analyses of findings from the Women's Health Initiative (WHI) suggest that women who begin hormone therapy within 10 years of menopause may have less risk of coronary heart disease (CHD) due to hormone therapy than women farther from menopause.

3 Apr 2007

Xenotransplantation - what are the barriers?

Given the huge shortage of donor organs, researchers have been trying to find ways to transplant animal organs across different species (known as "xenotransplantation"), with the eventual aim of transplanting animal organs into humans.

2 Apr 2007

Optical biopsy finds cancers in first tests on human tissue

In its first laboratory tests on human tissue, a light-based probe built by researchers at Duke University's Pratt School of Engineering almost instantly detected the earliest signs of cancer in cells that line internal organs.

2 Apr 2007

Lack of Olig1 protein in lung tumors may increase risk of death

A study of human lung tumors indicates that lung cancer patients who lack a particular protein may do more poorly than those with normal levels of that same protein.

2 Apr 2007

Costs due to complications from preterm birth are staggering

In Canada, outlays for specialized care of surviving preterm infants are estimated to be almost $2 billion per year.

2 Apr 2007

Guidelines for obstetric anesthesia revised

Recognizing that each patient's labor and delivery experience is unique, the American Society of Anesthesiologists (ASA) Practice Guidelines for Obstetric Anesthesia were recently revised to enhance the quality of anesthetic care for obstetric patients, improve patient safety by reducing the incidence and severity of anesthesia-related complications, and increase patient satisfaction.

2 Apr 2007

ESMO explores collaboration to fight cancer on all fronts

Leading figures in the global fight against lung cancer are meeting in the city of Geneva, Switzerland this week to discuss the latest tools for preventing and treating chest malignancies, which kill more than 1.3 million people each year.

2 Apr 2007

Single-walled carbon nanotubes may pose health risks

DNA-wrapped single-walled carbon nanotubes (SWCNTs) shorter than about 200 nanometers readily enter into human lung cells and so may pose an increased risk to health, according to scientists at the National Institute of Standards and Technology (NIST).

2 Apr 2007

Radiofrequency (RF) ablation effective for treating inoperable lung cancer

A minimally invasive procedure known as radiofrequency (RF) ablation is effective for treating lung cancer in patients who are not candidates for surgery, according to a Rhode Island Hospital study published in the April issue of the journal Radiology.

31 Mar 2007

RF ablation used to treat early-stage, inoperable cancer

Lung cancer patients who are not candidates for surgery now have another safe and effective treatment option: radiofrequency (RF) ablation, according to a new study published in the April issue of the journal Radiology.

31 Mar 2007

Natural mechanism for immune suppression may lead to new cancer drugs

A natural mechanism pirated by tumors and HIV to evade the immune response is opening the door to better treatment for these conditions, researchers say.

31 Mar 2007

Annual computed tomography screening identifies a high proportion of patients with early-stage lung cancer

Lung cancer remains the leading cause of cancer death in both men and women, killing more people than breast, prostate and colon cancers combined, according to the American Cancer Society (ACS). According to the study, the estimated cure rate for lung cancer in the absence of screening is approximately 5 percent, but increases significantly when the cancer is diagnosed and treated at its earliest stage.

31 Mar 2007

Bronchial thermoplasty study

A new report published in the prestigious New England Journal of Medicine (NEJM) shows that patients treated with bronchial thermoplasty, the first non-drug treatment for asthma, demonstrated an overall improvement in asthma control.

30 Mar 2007

Genetic culprits of idiopathic pulmonary fibrosis

Scientists at Johns Hopkins have identified the genetic culprits that trigger a hereditary form of a fatal lung disease.

30 Mar 2007

Blood pressure control with Clevidipine

Researchers report that an investigational anti-hypertensive therapy may perform better in controlling blood pressure than standard treatments for patients undergoing heart surgery, during a presentation at the American College of Cardiology's 56th Annual Scientific Session.

30 Mar 2007

Decoy receptor 3 expressed in rheumatic synovial fibroblasts protects the cells against Fas-induced apoptosis

A complex autoimmune disease, rheumatoid arthritis (RA) is characterized by chronic inflammation and progressive joint damage. This process begins with hyperplasia, or excessive increase in size and thickness, of synovial tissue. Along with provoking cartilage and bone destruction, this abnormal tissue growth is resistant to apoptosis, the natural cell death vital to the generation of healthy new cells.

30 Mar 2007